Inventor

DEQIANG NIU

Inventor

Overview

4→

Patents

2022–2025

Patent span

Chemistry

Primary field (CPC C)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds25%

A61KPreparations for medical, dental or toiletry purposes19%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%

C12NMicroorganisms or enzymes6%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%

C12YEnzymes6%

G01NInvestigating or analysing materials by determining their chemical or physical properties6%

G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology6%

G16CComputational chemistry6%

PatentTitleYear

12,473,304Heterocyclic PAD4 inhibitors2025 11,584,757MK2 inhibitors and uses thereof2023 11,542,492Ligand-directed covalent modification of protein2023 11,351,1682,4-disubstituted pyrimidines useful as kinase inhibitors2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to CELGENE CAR LLC (3)· patent assignee history

2022–2025Based in US· patent location history

2025Patents assigned to BRISTOL MYERS SQUIBB CO (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CELGENE CAR LLC	3	2022–2023
BRISTOL MYERS SQUIBB CO	1	2025

Locations

Location	Patents	Span
US	4	2022–2025